DK1459748T3 - (S,S)-reboxetin til behandling af perifer neuropati - Google Patents

(S,S)-reboxetin til behandling af perifer neuropati

Info

Publication number
DK1459748T3
DK1459748T3 DK04013379T DK04013379T DK1459748T3 DK 1459748 T3 DK1459748 T3 DK 1459748T3 DK 04013379 T DK04013379 T DK 04013379T DK 04013379 T DK04013379 T DK 04013379T DK 1459748 T3 DK1459748 T3 DK 1459748T3
Authority
DK
Denmark
Prior art keywords
reboxetine
treatment
peripheral neuropathy
neuropathy
peripheral
Prior art date
Application number
DK04013379T
Other languages
Danish (da)
English (en)
Inventor
Saeeduddin Ahmed
Lars Birgerson
Pasquale Cetera
Robert Clyde Marshall
Robert Mcarthur
Duncan P Taylor
Erik H F Wong
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32831120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1459748(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Priority claimed from EP00941659A external-priority patent/EP1196172B1/de
Application granted granted Critical
Publication of DK1459748T3 publication Critical patent/DK1459748T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04013379T 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati DK1459748T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US14196899P 1999-07-01 1999-07-01
US14413199P 1999-07-16 1999-07-16
US15825699P 1999-10-06 1999-10-06
US17038199P 1999-12-13 1999-12-13
EP00941659A EP1196172B1 (de) 1999-07-01 2000-06-22 (S,S)-Reboxetine zur Behandlung chronischer Schmerzen
PCT/US2000/017256 WO2001001973A2 (en) 1999-07-01 2000-06-22 Highly selective norepinephrine reuptake inhibitors and methods of using the same

Publications (1)

Publication Number Publication Date
DK1459748T3 true DK1459748T3 (da) 2005-07-04

Family

ID=32831120

Family Applications (5)

Application Number Title Priority Date Filing Date
DK04013379T DK1459748T3 (da) 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati
DK04025513T DK1500395T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04025514T DK1500396T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner
DK04013383T DK1459751T3 (da) 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine

Family Applications After (4)

Application Number Title Priority Date Filing Date
DK04025513T DK1500395T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04025514T DK1500396T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner
DK04013383T DK1459751T3 (da) 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine

Country Status (3)

Country Link
EP (10) EP1459750B1 (de)
DK (5) DK1459748T3 (de)
SI (1) SI1196172T1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070029740A (ko) * 2004-06-09 2007-03-14 화이자 인코포레이티드 통증 치료를 위한 레복세틴의 용도
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
AU9214498A (en) * 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
KR20010034758A (ko) * 1998-04-09 2001-04-25 로렌스 티. 마이젠헬더 신경 장애의 신규 치료 방법
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
SK14502000A3 (sk) * 1998-05-08 2001-05-10 Pharmacia And Upjohn Company Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu
CN1331576A (zh) * 1998-06-29 2002-01-16 药品应用协会有限公司 用于缓解疼痛的方法和经皮组合物
SE9904750D0 (sv) * 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
JP2003523382A (ja) * 2000-02-24 2003-08-05 ファルマシア・アンド・アップジョン・カンパニー 新規な薬物の組合せ

Also Published As

Publication number Publication date
DK1493442T3 (da) 2005-12-19
SI1196172T1 (sl) 2006-06-30
EP1629843A3 (de) 2006-03-15
EP1632235A2 (de) 2006-03-08
EP1459750B1 (de) 2005-06-01
EP1459749B1 (de) 2005-10-05
EP1632235A3 (de) 2006-06-14
DK1500395T3 (da) 2006-06-19
EP1493442A1 (de) 2005-01-05
EP1500395A1 (de) 2005-01-26
EP1500395B1 (de) 2006-03-08
EP1629843A2 (de) 2006-03-01
EP1459751B1 (de) 2005-09-14
EP1459751A1 (de) 2004-09-22
EP1459748A1 (de) 2004-09-22
EP1459748B8 (de) 2005-06-08
EP1459749A1 (de) 2004-09-22
EP1632234B1 (de) 2007-06-13
EP1493442B1 (de) 2005-09-28
EP1500396B1 (de) 2005-09-28
DK1500396T3 (da) 2005-12-19
EP1632234A3 (de) 2006-03-15
EP1500396A1 (de) 2005-01-26
EP1632234A2 (de) 2006-03-08
DK1459751T3 (da) 2005-12-19
EP1459748B1 (de) 2005-04-13
EP1459750A1 (de) 2004-09-22

Similar Documents

Publication Publication Date Title
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
BR0001826B1 (pt) fralda descartÁvel.
BR0214664B1 (pt) peça de vestuário absorvente.
NL1014915A1 (nl) Nieuwe behandelingsmethode.
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
BR0014932B1 (pt) conjunto de retenção.
DK1183269T3 (da) Svækkede mikroorganismer til behandlingen af infektion
BR0000706B1 (pt) fralda descartÁvel.
BR0001216B1 (pt) fralda descartÁvel.
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
BR0012043B1 (pt) composiÇço de tratamento de cabelo.
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
BR0004412B1 (pt) fralda descartÁvel.
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
IT1307028B1 (it) Bendaggio.
NL1015318A1 (nl) Verzekeren per kilo.
IT1311559B1 (it) Gabbia smontabile.
IT1317869B1 (it) Doccia.
ES1043857Y (es) Ortesis bitutora.
IT1311385B1 (it) Sezione operatrice regolabile per andanatore.
ES1043574Y (es) Anillo.
UA3308S (uk) Стіл, що встроюється
UA3310S (uk) Стіл, що встроюється
UA3306S (uk) Стіл, що встроюється